Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

cyclopia sequence 10Lung Neoplasms 3Pain 2Neoplasms, Plasma Cell 2Multiple Myeloma 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Sleepiness 1Peripheral Nervous System Diseases 1Parasomnias 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Laryngeal Diseases 1Hypesthesia 1Glioma 1Fatigue 1Exanthema 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Carcinoma 1Anxiety Disorders 1Anorexia 1Acute Pain 1

Interventions

Surveys and Questionnaires 4Therapeutics 2Psilocybin 2Ketamine 2Ultraviolet Therapy 1Self-Help Groups 1Relaxation Therapy 1Psychotherapy 1Psychosocial Intervention 1Propranolol 1Oxygen 1Nitrous Oxide 1Niacin 1N-Methyl-3,4-methylenedioxyamphetamine 1Minocycline 1Midazolam 1Melatonin 1Interviews as Topic 1Imagery, Psychotherapy 1Hormones 1Exercise Test 1Early Intervention, Educational 1Donepezil 1Dehydroepiandrosterone 1Counseling 1Cognitive Behavioral Therapy 1Cannabidiol 1Autogenic Training 1Anesthesia, Local 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Anxiety Disorders × Minocycline × Clear all
NCT02203552 2025-01-08

Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
56 enrolled 9 charts
Breast

Anxiety Disorders, Breast Neoplasms, Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡